Licks Attorneys - Media & Publications

Carlos Aboim

Rodolfo Barreto

Isabella Benevides

Why Brazil stands out as a key jurisdiction for SEP enforcement in 2025



February 20, 2025

IAM

2025

Licks Attorneys

DivX’s enforcement victories add to Brazil’s reputation as SEP enforcement hub



February 18, 2025

IAM

2025

Licks Attorneys

Samsung’s antitrust attack on ZTE over SEP licensing confirmed; ZTE won Brazilian preliminary injunction last month



February 14, 2025

ip fray

2025

Carlos Aboim

Rodolfo Barreto

DivX strikes license deal with Hisense owing exclusively to Brazilian patent enforcement



February 11, 2025

ip fray

2025

Eduardo Hallak

Juliana Neves

Isabella Bonisolo

Juliana Castelo

Trends and Developments - Life Sciences & Pharma IP Litigation 2025



January 28, 2025

Chambers

2025

Regis Arslanian

FIESP renova mandato de Regis Arslanian como conselheiro do COSCEX



January 16, 2025

Migalhas

2025

Juliana Neves

Isabella Bonisolo

O Marco Legal dos Bioinsumos e seus impactos no setor agrícola



January 8, 2025

Jota

2025

Ricardo Campello

Paula Carvalho

Roger Novello

Brazil reinstates preference margins for the procurement of drugs



December 23, 2024

Lexology

2024

Ricardo Campello

Paula Carvalho

Roger Novello

Brasil volta a instituir margens de preferência para compra de medicamentos



December 20, 2024

Jota

2024

Douglas Leite

Flavio Buzanovsky

Fernanda Cohen

Licks Attorneys welcomes back three professionals



December 18, 2024

The Legal 500

2024

Eduardo Hallak

Gislaine Zulli

Cenário de inovação no Brasil: Uma breve análise



December 17, 2024

Migalhas

2024

Juliana Castelo

Disputas de Nome de Domínio: panorama das soluções adequadas à resolução dos conflitos no Brasil e no Exterior



December 11, 2024

Tirant Brasil

2024

Carlos Aboim

Alexandre Dalmasso

Brazil now “hot jurisdiction” for IP strategy, leading patent owners say



November 5, 2024

IAM

2024

Otto Licks

Carlos Aboim

Rodolfo Barreto

Brazil: SEPs and FRAND – litigation, policy and latest developments



October 22, 2024

IAM

2024

Liliane Roriz

Abel Gomes

How specialisation transformed Brazil’s patent system



October 14, 2024

WIPR

2024

Eduardo Hallak

Rafaella Oliveira

Danielle Altomari

Bruna Luna

CRISPR-CAS-based inventions: Advantages for agriculture and an overview of patent protection in Brazil



October 11, 2024

Lexology

2024

Carolina Caetano

Arthur Ferreira

O registro de nomes como marca: Uma análise do caso Vidal v Elster



October 10, 2024

Migalhas

2024

Alexandre Dalmasso

Ricardo Campello

Paula Carvalho

Eduardo Machado

Brazilian Federal Medical Board imposes stricter rules for transparency



October 9, 2024

Lexology

2024

Otto Licks

Nuno Carvalho

Catia Regina Gentil

Otavio Beaklini

João Cruz

Um é pouco, dois é bom, três é demais? Para se requerer exame de um pedido de patente, três anos é muito melhor



October 7, 2024

Migalhas

2024

Ricardo Campello

Paula Carvalho

Camila Cardoso

Roger Novello

Beatriz Santos

Does Law 14,874 address the obstacles that prevented Brazil from becoming a hub for clinical research? - Part II



October 1, 2024

Lexology

2024

Licks Attorneys

Justiça manda Amazon acelerar abandono de tecnologia por trás do 4K no Brasil



September 27, 2024

O Globo

2024

Ricardo Campello

Paula Carvalho

Eduardo Machado

STJ Ruling Could Shape Drug Advertising Landscape: Industry Must Stay Vigilant



September 26, 2024

Lexology

2024

Abel Gomes

Liliane Roriz

The success of the Brazilian utility patent system fostered by the Brazilian Judicial Branch



September 25, 2024

Lexology

2024

Ricardo Campello

Paula Carvalho

Camila Cardoso

Roger Novello

Beatriz Santos

Lei 14.874 e obstáculos para Brasil virar hub de pesquisa clínica – parte 2



September 24, 2024

Jota

2024



No results found.

Please try different filters.

Media & publications

Why Brazil stands out as a key jurisdiction for SEP enforcement in 2025

DivX’s enforcement victories add to Brazil’s reputation as SEP enforcement hub

Samsung’s antitrust attack on ZTE over SEP licensing confirmed; ZTE won Brazilian preliminary injunction last month

DivX strikes license deal with Hisense owing exclusively to Brazilian patent enforcement

Trends and Developments - Life Sciences & Pharma IP Litigation 2025

FIESP renova mandato de Regis Arslanian como conselheiro do COSCEX

O Marco Legal dos Bioinsumos e seus impactos no setor agrícola

Brazil reinstates preference margins for the procurement of drugs

Brasil volta a instituir margens de preferência para compra de medicamentos

Licks Attorneys welcomes back three professionals

Cenário de inovação no Brasil: Uma breve análise

Disputas de Nome de Domínio: panorama das soluções adequadas à resolução dos conflitos no Brasil e no Exterior

Brazil now “hot jurisdiction” for IP strategy, leading patent owners say

Brazil: SEPs and FRAND – litigation, policy and latest developments

How specialisation transformed Brazil’s patent system

CRISPR-CAS-based inventions: Advantages for agriculture and an overview of patent protection in Brazil

O registro de nomes como marca: Uma análise do caso Vidal v Elster

Brazilian Federal Medical Board imposes stricter rules for transparency

Um é pouco, dois é bom, três é demais? Para se requerer exame de um pedido de patente, três anos é muito melhor

Does Law 14,874 address the obstacles that prevented Brazil from becoming a hub for clinical research? - Part II

Justiça manda Amazon acelerar abandono de tecnologia por trás do 4K no Brasil

STJ Ruling Could Shape Drug Advertising Landscape: Industry Must Stay Vigilant

The success of the Brazilian utility patent system fostered by the Brazilian Judicial Branch

Lei 14.874 e obstáculos para Brasil virar hub de pesquisa clínica – parte 2

事務所

リオデジャネイロ

サンパウロ

ブラジリア

クリチバ

東京

新型コロナウィルス感染症安全対策認証事務所